Cargando…

Endometrial preservation during resection of type II and type III submucosal fibroids

BACKGROUND AND OBJECTIVES: Hysteroscopic myomectomy is considered the gold-standard treatment of submucosal fibroids. However, it is associated with disruption of the endometrium which may lead to complications such as intrauterine adhesions and loss of functional endometrium. In this video article...

Descripción completa

Detalles Bibliográficos
Autores principales: Vorona, G, Saridogan, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Universa Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350949/
https://www.ncbi.nlm.nih.gov/pubmed/36206803
http://dx.doi.org/10.52054/FVVO.14.3.038
_version_ 1785074245895716864
author Vorona, G
Saridogan, E
author_facet Vorona, G
Saridogan, E
author_sort Vorona, G
collection PubMed
description BACKGROUND AND OBJECTIVES: Hysteroscopic myomectomy is considered the gold-standard treatment of submucosal fibroids. However, it is associated with disruption of the endometrium which may lead to complications such as intrauterine adhesions and loss of functional endometrium. In this video article we describe a technique to resect Type III and Type II fibroids whilst minimising the loss of overlying endometrium. MATERIALS AND METHODS: We present two patients with type II/III submucosal fibroids with minimal or no intracavity component. The resection technique we demonstrate comprises either making an endometrial incision or making a small opening in the overlying endometrium to expose the fibroid pseudocapsule. Subsequent steps of resection are then performed through this small opening. Thus, complete resection is achieved without further resection of the endometrium. MAIN OUTCOME MEASURES: Evidence of endometrial healing and absence of intrauterine synechiae on follow up outpatient hysteroscopy or ultrasound scan. RESULTS: Full resection was achieved in both patients with no or minimal loss of overlying endometrium. A follow up outpatient hysteroscopy was performed 8 weeks later in the first patient, demonstrating completely healed uterine cavity. She had a successful conception and delivery following IVF treatment for male factor infertility. The second patient is currently in the process of IVF treatment. CONCLUSIONS: Our technique enables endometrial preservation and potentially better reproductive outcomes following resection of type II and type III submucosal fibroids. Larger scale studies are required to elucidate long term outcomes on bigger patient population.
format Online
Article
Text
id pubmed-10350949
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Universa Press
record_format MEDLINE/PubMed
spelling pubmed-103509492023-07-18 Endometrial preservation during resection of type II and type III submucosal fibroids Vorona, G Saridogan, E Facts Views Vis Obgyn Video Article BACKGROUND AND OBJECTIVES: Hysteroscopic myomectomy is considered the gold-standard treatment of submucosal fibroids. However, it is associated with disruption of the endometrium which may lead to complications such as intrauterine adhesions and loss of functional endometrium. In this video article we describe a technique to resect Type III and Type II fibroids whilst minimising the loss of overlying endometrium. MATERIALS AND METHODS: We present two patients with type II/III submucosal fibroids with minimal or no intracavity component. The resection technique we demonstrate comprises either making an endometrial incision or making a small opening in the overlying endometrium to expose the fibroid pseudocapsule. Subsequent steps of resection are then performed through this small opening. Thus, complete resection is achieved without further resection of the endometrium. MAIN OUTCOME MEASURES: Evidence of endometrial healing and absence of intrauterine synechiae on follow up outpatient hysteroscopy or ultrasound scan. RESULTS: Full resection was achieved in both patients with no or minimal loss of overlying endometrium. A follow up outpatient hysteroscopy was performed 8 weeks later in the first patient, demonstrating completely healed uterine cavity. She had a successful conception and delivery following IVF treatment for male factor infertility. The second patient is currently in the process of IVF treatment. CONCLUSIONS: Our technique enables endometrial preservation and potentially better reproductive outcomes following resection of type II and type III submucosal fibroids. Larger scale studies are required to elucidate long term outcomes on bigger patient population. Universa Press 2022-09-30 /pmc/articles/PMC10350949/ /pubmed/36206803 http://dx.doi.org/10.52054/FVVO.14.3.038 Text en Copyright © 2022 Facts, Views & Vision https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Video Article
Vorona, G
Saridogan, E
Endometrial preservation during resection of type II and type III submucosal fibroids
title Endometrial preservation during resection of type II and type III submucosal fibroids
title_full Endometrial preservation during resection of type II and type III submucosal fibroids
title_fullStr Endometrial preservation during resection of type II and type III submucosal fibroids
title_full_unstemmed Endometrial preservation during resection of type II and type III submucosal fibroids
title_short Endometrial preservation during resection of type II and type III submucosal fibroids
title_sort endometrial preservation during resection of type ii and type iii submucosal fibroids
topic Video Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350949/
https://www.ncbi.nlm.nih.gov/pubmed/36206803
http://dx.doi.org/10.52054/FVVO.14.3.038
work_keys_str_mv AT voronag endometrialpreservationduringresectionoftypeiiandtypeiiisubmucosalfibroids
AT saridogane endometrialpreservationduringresectionoftypeiiandtypeiiisubmucosalfibroids